Hawthorn 525 mg

Hawthorn 525 mg

Solaray4.7 (2,114 ratings)
Format:Capsule Quantity: 100 VegCap(s) · 50 servings
Goals
$10.39 $0.20 per serving

About this product

Two capsules provide 1,050 mg of hawthorn, a substantial amount for non-standardized plant material. The formula avoids unrelated supporting ingredients and keeps its purpose clear.

No species, plant part, extract ratio, or active marker is provided. That means the label cannot show how the whole-herb serving compares with standardized preparations.

The large bottle and practical two-capsule serving support regular low-cost use. It best fits users who accept whole-herb variability and want a focused hawthorn product.

Who is it for
  • Adults seeking a substantial whole-herb dose
  • Budget-conscious hawthorn users
  • People comfortable with two capsules
Best for
  • High-dose plain hawthorn
  • Simple single-herb use
  • Economical long-term supplementation

Pros

  • Supplies 1,050 mg hawthorn
  • Simple single-ingredient design
  • Large number of capsules
  • Two-capsule serving

Cons

  • No active-marker standardization
  • Species is not identified
  • Plant part is missing
  • Potency may vary from standardized extracts

Warnings

  • Hawthorn may add to antihypertensive medicines or nitrates and cause excessive blood-pressure reduction.
  • People taking digoxin or other heart medicines should use hawthorn only with prescriber guidance.
  • Dizziness or faintness after starting the product warrants stopping use and seeking advice.

Product analysis

81 out of 100
A substantial, economical whole-herb dose offers straightforward hawthorn use, but absent botanical and potency details limit predictability.

AI assessment of the formula, label and price. How scoring works

Nutrient quality80

The whole-herb hawthorn lacks species, plant-part, and active-marker details. The substantial amount is well aligned with non-concentrated herb use, and the single botanical offers a focused but narrow cardiovascular pathway.

.
Ingredient transparency78

Every listed active has a specific amount and no proprietary blend obscures the formula. Complete intake directions and inactive ingredients are not supplied, leaving part of the label unverified.

.
Customer satisfaction73

The supplied aggregate satisfaction level is strong. The extensive feedback volume makes the aggregate dependable.

.
Value for money92

The strong whole-herb amount supports the low cost despite limited source detail. The serving offers strong cost efficiency, and the product compares well for basic powder but not for standardized quality.

.
Format
Capsule
Container
100 VegCap(s)
Per serving
$0.20
Customer rating
4.7 · 2,114 ratings
Report analysis

Goals

Heart Health
Impact
High effect
A+ Ingredient FitD- PathwaysC+ EvidenceA+ Formulation Logic
Study evidence
Hawthorn Supportive 27 studies
Cardiovascular Support
Impact
Highest effect
A+ Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic
Hawthorn · 1050 mg

Hawthorn is the only cardiovascular ingredient listed, at 1,050 mg per serving, and it relates to vascular tone. The supplied note cautions that generic hawthorn is not established for routine cardiovascular support: a large WS 1442 heart-failure trial did not significantly improve its primary cardiac-event outcome, and this label does not identify that extract.

How this product is rated for Cardiovascular Support

Ingredient fit97

Hawthorn is the only active linked to this goal, and its serving amount reaches the relevant reference.
Goal fit
No off-goal active appears in the supplied ingredient facts, and hawthorn is linked to cardiovascular support.
Dose adequacy
The 1,050 mg serving amount reaches the reference used for the supplied hawthorn evidence.

Pathways55

Hawthorn contributes to vascular tone, leaving other cardiovascular routes unrepresented.
Depth
Vascular tone is the best-covered route for this single ingredient.
Breadth
Only one of the three main cardiovascular routes receives substantial coverage.

Evidence81

Hawthorn has trial representation, but the supplied note limits what the generic label can establish for routine cardiovascular use.
Evidence strength
The evidence ceiling is below the strongest available for this goal.
Studied preparation
The research includes WS 1442, but the generic label does not identify that specific extract.

Formulation logic100

Hawthorn works alone, with no relevant partner gap or listed conflict.
Partner coverage
Hawthorn does not require a partner ingredient.
Conflicts
No relevant conflict was detected among the listed ingredients.
Effective doses
The serving amount reaches the minimum amount used in the relevant evidence.
Study evidence
Hawthorn Supportive 28 studies

Ingredients

IngredientAmount per servingScore
Hawthorn
1050 mg 52
Adults 18–50
Report overview
Hawthorn · 1050 mg OverallScore52
F Composition And Label DisclosureA+ Commercial Price And Usability
The product lists Hawthorn without a marker percentage, preparation ratio, or species name. Its selected serving price is low.
How this ingredient is rated

Composition and Label Disclosure29

The available details name Hawthorn but don't specify a marker percentage, preparation ratio, or species.
Marker and Preparation Disclosure
The Hawthorn amount is stated, but no marker percentage or preparation ratio is provided.
Species Name Disclosure
The saved details don't identify a specific hawthorn species.

Composition and Label Disclosure

No dose or safety disclosure items are compared for Hawthorn here.

Commercial Price and Usability100

The cost per selected serving is low.
Commercial Price per Labeled Serving
The selected serving falls in a lower-cost range.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledHeart Health Cardiovascular Support forHawthorn
  2. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E · The American journal of medicine · 2003
    Meta-analysis632 participants13 studies pooledHeart Health forHawthorn
  3. Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.
    Zick SM; Vautaw BM; Gillespie B; Aaronson KD · European journal of heart failure · 2010
    Randomized trial120 participantsHeart Health forHawthorn
  4. Effects of Hawthorn Fruit Extract Drink in Chinese Patients With Mild Hypertension and/or Hyperlipidaemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Zeng W; Chu TTW; Fok BSP; Ho WKK; Chan JCN; Tomlinson B · Dose-response : a publication of International Hormesis Society · 2024
    Randomized trial61 participantsCardiovascular Support forHawthorn
  5. Hawthorn Herb Increases the Risk of Bleeding after Cardiac Surgery: An Evidence-Based Approach.
    Rababa'h AM; Altarabsheh SE; Haddad O; Deo SV; Obeidat Y; Al-Azzam S · The heart surgery forum · 2017
    Observational study116 participantsCardiovascular Support forHawthorn
  6. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  7. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  8. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  9. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  10. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn
  11. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2002
    Randomized trial40 participantsHeart Health forHawthorn
  12. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Meta-analysis687 participants10 studies pooledHeart Health forHawthorn